P53: stability from the ubiquitin–proteasome system and specific 26S proteasome inhibitors (2022)
Fonte: ACS Omega. Unidade: FMRP
Assuntos: APOPTOSE, NEOPLASIAS, GENÉTICA, PEPTÍDEOS, PROTEÍNAS
ABNT
PATROCINIO, Andressa Barban do e RODRIGUES, Vanderlei e MAGALHÃES, Lizandra Guidi. P53: stability from the ubiquitin–proteasome system and specific 26S proteasome inhibitors. ACS Omega, v. 7, n. 5, p. 3836-3843, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsomega.1c04726. Acesso em: 25 dez. 2024.APA
Patrocinio, A. B. do, Rodrigues, V., & Magalhães, L. G. (2022). P53: stability from the ubiquitin–proteasome system and specific 26S proteasome inhibitors. ACS Omega, 7( 5), 3836-3843. doi:10.1021/acsomega.1c04726NLM
Patrocinio AB do, Rodrigues V, Magalhães LG. P53: stability from the ubiquitin–proteasome system and specific 26S proteasome inhibitors [Internet]. ACS Omega. 2022 ; 7( 5): 3836-3843.[citado 2024 dez. 25 ] Available from: https://doi.org/10.1021/acsomega.1c04726Vancouver
Patrocinio AB do, Rodrigues V, Magalhães LG. P53: stability from the ubiquitin–proteasome system and specific 26S proteasome inhibitors [Internet]. ACS Omega. 2022 ; 7( 5): 3836-3843.[citado 2024 dez. 25 ] Available from: https://doi.org/10.1021/acsomega.1c04726